Henri Gautier Ouedraogo, Alberto Matteelli, Giorgia Sulis, Tegwinde Rebeca Compaore, Serge Diagbouga, Simon Tiendrebeogo, . . . Seni Kouanda. (2020). Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis-HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per week. BMC.
Chicago Style (17th ed.) CitationHenri Gautier Ouedraogo, et al. Pharmacokinetics of Plasma Lopinavir and Ritonavir in Tuberculosis-HIV Co-infected African Adult Patients Also Receiving Rifabutin 150 or 300 mg Three Times Per Week. BMC, 2020.
MLA (9th ed.) CitationHenri Gautier Ouedraogo, et al. Pharmacokinetics of Plasma Lopinavir and Ritonavir in Tuberculosis-HIV Co-infected African Adult Patients Also Receiving Rifabutin 150 or 300 mg Three Times Per Week. BMC, 2020.